Enhanced anti-tumor effects achieved in a murine tumor model using combination therapy of recombinant human manganese superoxide dismutase and adriamycin

Biochemical and Biophysical Research Communications

Volumn 370, Issue 4, 2008, Pages 663-668

  Chen, Che Sheng ^a   Zhao, Qing ^a   Wang, Jia ^a   Rong, Jing Jing ^a   Yuan, Qin Sheng ^b   Guo, Qing Long ^a   Wu, Wu Tong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Adriamycin; CD4; CD8; Combination chemotherapy; Recombinant human manganese superoxide dismutase

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DOXORUBICIN; MANGANESE SUPEROXIDE DISMUTASE;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; GROWTH INHIBITION; HISTOPATHOLOGY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DOXORUBICIN; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; RECOMBINANT PROTEINS; SARCOMA 180; SUPEROXIDE DISMUTASE;

MURINAE; MUS;

EID: 46349107726     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.04.022     Document Type: Article

References (20)

1. Sato T., Machida T., Takahashi S., Iyama S., Sato Y., Kuribayashi K., Takada K., Oku T., Kawano Y., Okamoto T., Takimoto R., Matsunaga T., Takayama T., Takahashi M., Kato J., and Niitsu Y. Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in Jurkat cells. J. Immunol. 173 (2004) 285-296
2. Xu Y., Krishnan A., Wan X.S., Majima H., Yeh C.C., Ludewig G., J Kasarskis E., and Clair D.K.St. Mutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase gene in cancer cells. Oncogene 18 (1999) 93-102
3. Huang Y.H., He T., and Domann F.E. Decreased expression of manganese superoxide dismutase in transformed cells is associated with increased cytosine methylation of the SOD2 gene. DNA Cell Biol. 18 (1999) 643-652
4. Hernandez-Saavedra D., and McCord J.M. Paradoxical effects of thiol reagents on Jurkat cells and a new thiol-sensitive mutant form of human mitochondrial superoxide dismutase. Cancer Res. 63 (2003) 159-163
5. Chuang T.C., Liu J.Y., Lin C.T., Tang Y.T., Yeh M.H., Chang S.C., Li J.W., and Kao M.C. Human manganese superoxide dismutase suppresses HER2/neu-mediated breast cancer malignancy. FEBS Lett. 581 (2007) 4443-4449
6. Zhao Y., Chaiswing L., Oberley T.D., Batinic-Haberle I., Clair W.St., Epstein C.J., and Clair D.St. A mechanism-based antioxidant approach for the reduction of skin carcinogenesis. Cancer Res. 65 (2005) 1401-1405
7. Daosukho C., Ittarat W., Lin S., Sawyer D.B., Kiningham K., Lien Y.C., and Clair D.K.St. Induction of manganese superoxide dismutase (MnSOD) mediates cardioprotective effect of tamoxifen (TAM). J. Mol. Cell. Cardiol. 39 (2005) 792-803
8. Dolgachev V., Oberley L.W., Huang T.T., Kraniak J.M., Tainsky M.A., Hanada K., and Separovic D. A role for manganese superoxide dismutase in apoptosis after photosensitization. Biochem. Biophys. Res. Commun. 332 (2005) 411-417
9. Asmis R., Qiao M., Rossi R.R., Cholewa J., Xu L., and Asmis L.M. Adriamycin promotes macrophage dysfunction in mice. Free Radic. Biol. Med. 41 (2006) 165-174
10. Chen C., Chen Y., Wu Q., Yuan Q., and Wu W. Optimization of high-cell-density fermentation condition of recombinant human manganese superoxide dismutase. J. China Pharm. Univ. 38 (2007) 472-476
11. Chen Y., Chen C., Wu Q., Zhao J., and Yuan Q. Study on purification condition of recombinant human manganese superoxide dismutase. Food Drug 9 (2007) 1-5
12. Singal P., Li T., Kumar D., Danelisen I., and Iliskovic N. Adriamycin-induced heart-failure: mechanism and modulation. Mol. Cell. Biochem. 207 (2000) 77-86
13. De Beer E.L., Bottone A.E., and Voest E.E. Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review. Eur. J. Pharmacol. 415 (2001) 1-11
14. Sadzuka Y., Sugiyama T., and Sonobe T. Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance. Toxicol. Lett. 114 (2000) 155-162
15. Geetha A., Sankar R., Marar T., and Devi C.S. Alpha-tocopherol reduces doxorubicin-induced toxicity in rats-histological and biochemical evidences. Indian J. Physiol. Pharmacol. 34 (1990) 94-100
16. Bravo-Cuellar A., Gomez-Contreras P.C., Lerma-Diaz J.M., Hernandez-Flores G., Dominguez-Rodriguez J.R., Ortiz-Lazareno P., Cervantes-Munguia R., and Orbach-Arbouys S. In vivo modification of adriamycin-induced apoptosis in L-5178Y lymphoma cell-bearing mice by (+)-α-tocopherol and superoxide dismutase. Cancer Lett. 229 (2005) 59-65
17. Liu Y., Liu Y., Zhao J., Hao X., Wang X., and Yao S. Studies on tumor cell apoptosis with SOD and its anti-oxidation effect I. The effect of SOD on apoptosis of tumor cell in DDP, ADM and VP16. J. Radiat. Res. Radiat. Process 22 (2004) 114-122
18. Liu Y., Liu Y., Zhao J., Hao X., Wang X., and Yao S. Studies on tumor cell apoptosis with SOD and its anti-oxidation effect IV. The protection effect of SOD on oxidized damage of normal tissue with tumor-bearing mice with SOD. J. Radiat. Res. Radiat. Process 22 (2004) 297-302
19. Kogawa K., Muramatsu H., Tanaka M., Nishihori Y., Hagiwara S., Kuribayashi K., Nakamura K., Koike K., Sakamaki S., and Niitsu Y. Enhanced inhibition of experimental metastasis by the combination chemotherapy of Cu-Zn SOD and adriamycin. Clin. Exp. Metast. 17 (1999) 239-244
20. Yue W.F., Li G.L., Liu J.M., Sun J.T., Sun H.X., Li X.H., Wu X.F., and Miao Y.G. Anti-oxidation and immune responses in mice upon exposure to manganese superoxide dismutase expressed in silkworm larvae, Bombyx mori L. Cell Biol. Int. 31 (2007) 974-978